Clinical Trial Update: Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial completed by Sanofi comparing a basal-plus-one insulin regimen with a biphasic insulin regimen in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED